Oncopeptides AB (publ) (STO:ONCO)
Sweden · Delayed Price · Currency is SEK 1.780
-0.109 (-5.77%)
Sep 4, 2026, 5:29 PM CET
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 746.7 million as of September 4, 2026. Its market cap has decreased by -31.66% in one year.
Market Cap
746.70M
Enterprise Value
724.26M
Revenue
95.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.78
ChartMarket Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 746.70M, a decrease of -55.28%. That is a compound annual growth rate of -8.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 746.70M | -43.02% |
| Dec 30, 2025 | 1.31B | 291.35% |
| Dec 30, 2024 | 334.83M | -53.79% |
| Dec 29, 2023 | 724.64M | -36.76% |
| Dec 30, 2022 | 1.15B | 81.18% |
| Dec 30, 2021 | 632.45M | -94.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genovis AB (publ.) | 1.45B |
| Medivir AB | 1.16B |
| AlzeCure Pharma AB | 1.12B |
| SynAct Pharma AB | 976.61M |
| Infant Bacterial Therapeutics AB | 874.30M |
| FluoGuide | 590.21M |
| Mendus AB | 488.07M |
| Xspray Pharma AB | 477.01M |